Drug Discovery World
APRIL 24, 2024
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has supported the use of artificial intelligence (AI) to deliver benefit for patients, life science companies and society, in response to the EU Artificial Intelligence (AI) Act.
pharmaphorum
JUNE 16, 2021
Borrowing from the Computer-Aided Design and Manufacturing (CAD/CAM) approaches in the semiconductor industry, a similar concept, called Computer-Aided Biology (CAB), can be applied to the life sciences. Life sciences are on the cusp of a quantum leap, fuelled in part by the spotlight on digitalisation created by the COVID-19 pandemic.
pharmaphorum
APRIL 5, 2022
“When you stand back and look at that overall context, what seems to have happened is that pharma and investors have suddenly gone, ‘You know what, maybe you can do these quicker and faster without breaking things’,” says managing director of life sciences and healthcare for Silicon Valley Bank UK, Nooman Haque. “If
Expert insights. Personalized for you.
52 
Let's personalize your content